MARCHANT VAN GERPEN: Open Payments
NPI 1396791794 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 5 payments from 4 companies in 2025. Trend: 2023 $378 · 2024 $150 · 2025 $185
Education: $98Food & beverage: $87
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $120 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Lundbeck LLC | 1 | $18 |
Products named: FANAPT, CAPLYTA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
